A retrospective study of patients treated from May of 1981 to April of 1994 was conducted. A
total of 245 patients with 299 hemangiomas were studied, which represents the largest …

Infantile hemangiomas (IHs) are the most common benign vascular tumors of infancy. Since
they predominantly involute without significant residua, the majority do not require treatment …

Objectives To determine the efficacy of systemic corticosteroid therapy in treating enlarging,
problematic cutaneous hemangiomas and to assess the relationship of dose to response …

Of 973 preterm infants, strawberry hemangioma was recorded in 124 during the first year of
life, giving an overall frequency of 12.7%. Male: female ratio was 1: 1.4. In 96 infants with …

Objective—The mechanism of neovascularization during the proliferative phase of infantile
hemangioma is poorly understood. It is known that circulating bone marrow-derived …

OBJECTIVE: We reviewed our experience with the use of oral corticosteroid therapy in
treating hemangiomas of infants to determine the optimal effective dose. STUDY DESIGN …

PURPOSE To characterize the MR appearance of the common hemangioma of infancy as
well as low-and high-flow vascular malformations of the head and neck. PATIENTS AND …

BACKGROUND: Telangiectatic matting and hyperpigmentation are some of the most
commonly observed side effects of sclerotherapy. Cutaneous necrosis is relatively rare and …

Learning Objectives: After studying this article, the participant should be able to: 1.
Differentiate clinically between hemangiomas and vascular malformations. 2. Describe …

Infantile hemangioma (IH), a benign vascular tumor, is the most common tumor of infancy,
with an incidence of 5%–10% at the end of the first year. The tumor displays a distinctive life …